4
Changes in Ownership
Eton Pharmaceuticals, Inc. Filed Acc 0001209191-19-018103
Options or other derivatives
- President & CEO acquired 250,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
BRYNJELSEN SEAN · President & CEO
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2019-02-20 | Grant or award : show line 1 in the form Stock option (right to buy) | +250,000 | 250,000 | D |
Loading xslF345X03/doc4.xml…